Prevention of axonal loss after immediate dosage titration of immunoglobulin in multifocal motor neuropathy
European Journal of Neurology · 2024
DOI: 10.1111/ene.16305 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Neurology, 2024. Verfasst von Ali Al-Zuhairy und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark. Hauptthemen laut MEDLINE: Axons, Polyneuropathies. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Takeda Pharmaceutical Company.
Abstract (Originalsprache)
Background
To evaluate whether ongoing axonal loss can be prevented in multifocal motor neuropathy (MMN) treated with immunoglobulin G (IgG), a group of patients with a median disease duration of 15.7 years (range: 8.3–37.8), treated with titrated dosages of immunoglobulins, was studied electrophysiologically at time of diagnosis and at follow‐up.
Results
At follow‐up, the Z‐score of the compound motor action potential amplitude of the median, fibular, and tibial nerves and the neurological performances were determined. In seven patients with a treatment‐free period of 0.3 years (0.2–0.4), there was no progression of axonal loss ( p = 0.2), whereas a trend toward further axonal loss by 1.3 Z‐scores (0.9–17.0, p = 0.06) was observed in five patients with a treatment‐free period of 4.0 years (0.9–9.0). The axonal loss in the group with a short treatment delay was significantly smaller than in the group with a longer treatment delay ( p = 0.02). Also, there was an association between treatment delay and ongoing axonal loss ( p = 0.004). The electrophysiological findings at follow‐up were associated with the isokinetic strength performance, the neurological impairment score, and the disability, supporting the clinical relevance of the electrophysiological estimate of axonal loss.
Conclusion
Swift initiation of an immediately titrated IgG dosage can prevent further axonal loss and disability in continuously treated MMN patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark.
- Department of Clinical Neurophysiology, Rigshospitalet, Copenhagen, Denmark.
- Department of Neuroscience, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Ali Al-Zuhairy
Förderung
- Takeda Pharmaceutical Company
Zitieren
APA
Al-Zuhairy, A., Jakobsen, J., & Krarup, C. (2024). Prevention of axonal loss after immediate dosage titration of immunoglobulin in multifocal motor neuropathy. European Journal of Neurology. https://doi.org/10.1111/ene.16305
Vancouver
Al-Zuhairy A, Jakobsen J, Krarup C. Prevention of axonal loss after immediate dosage titration of immunoglobulin in multifocal motor neuropathy. European Journal of Neurology. 2024. doi:10.1111/ene.16305
BibTeX
@article{AlZuhairy2024,
author = {Al-Zuhairy, Ali and Jakobsen, Johannes and Krarup, Christian},
title = {Prevention of axonal loss after immediate dosage titration of immunoglobulin in multifocal motor neuropathy},
journal = {European Journal of Neurology},
year = {2024},
doi = {10.1111/ene.16305}
}
EUVIMED